Nurix is Drug Discovery in United States that focus on Nurix Therapeutics Inc business. Founded in 2009. They cover business area such as Nurix Therapeutics Inc, development, commercialization, oral, small molecule therapy, cellular protein level, cancer, immune disorder, target protein degrader, bruton tyrosine kinase, BTK, inhibitor, Casitas B-lineage lymphoma proto-oncogene-B, CBL-B, its drug candidate, protein degradation portfolio, immuno-oncology indication.
2009
( 15 years old in 2024 )
Nurix Therapeutics Inc
-
1700 Owens Street
Suite 205
San Francisco, CA 94158
United States
Private
Nurix Therapeutics Incdevelopmentcommercializationoral, small molecule therapycellular protein levelcancerimmune disordertarget protein degraderbruton tyrosine kinaseBTKinhibitorCasitas B-lineage lymphoma proto-oncogene-BCBL-Bits drug candidateprotein degradation portfolioimmuno-oncology indication
* We use standard office opening hours in near Nurix's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Nurix is Drug Discovery business from United States that founded in 2009 (15 years old in 2024), Nurix business is focusing on Nurix Therapeutics Inc.
Nurix headquarter office and corporate office address is located in 1700 Owens Street Suite 205 San Francisco, CA 94158 United States.
Nurix was founded in United States.
In 2024, Nurix is currently focus on Nurix Therapeutics Inc sector.
Above is snippet of Google Trends for "Nurix Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Nurix, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
